Physician

Sujithraj Dommaraju, MD

According to 2025 Medicare claims, Sujithraj Dommaraju, MD (NPI: 1497310031) practices internal medicine in the Ithaca, NY market, with the plurality of this provider's patient population coming from Tompkins, NY. This provider's primary affiliated billing organization is CAYUGA MEDICAL ASSOCIATES, PC (NPI: 1679525455; TIN: 204356115) and primary practice location at 14850-1383. Dommaraju is affiliated with the Cayuga Health Partners (ACO ID: A3195), participating under the MSSP model.

Dommaraju's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 275 traditional Medicare patients, billed 1,116 HCPCS/CPT codes, and received $72,662 in Medicare payments. The top billing code was G0438 (Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit). Part D data shows 4,000 prescription claims across 553 beneficiaries totaling $431,219 in drug costs, led by Eliquis (Apixaban). DME data shows 46 claims. Open Payments data shows 1 records totaling $19. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,732 to $431,219. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	103	182	$15,197
2023	322	933	$62,199
2024	275	1,116	$72,662

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	30	77	$2,732
2020	51	255	$11,692
2021	36	210	$8,772
2022	122	343	$22,435
2023	389	2,328	$200,048
2024	553	4,000	$431,219

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	46	$1,503

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0438	Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	27	27	$161
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	129	129	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	183	351	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	85	105	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	25	27	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	40	3,360	$62,593
Penicillamine	Penicillamine	13	390	$45,472
Jardiance	Empagliflozin	28	1,798	$34,406
Ozempic	Semaglutide	22	966	$28,749
Xarelto	Rivaroxaban	15	1,130	$20,062

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,203
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$189
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	16	$111

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$19	Baxter Healthcare
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sujithraj Dommaraju, MD?

Tedicare shows public-source Medicare data for Sujithraj Dommaraju, MD (NPI 1497310031), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sujithraj Dommaraju, MD have ACO affiliation data?

Sujithraj Dommaraju, MD is shown with ACO affiliation data for Cayuga Health Partners (MSSP, ACO ID A3195).

What billing organization is linked to Sujithraj Dommaraju, MD?

Sujithraj Dommaraju, MD is linked to CAYUGA MEDICAL ASSOCIATES, PC (billing NPI 1679525455) in the available physician profile data.

Does Sujithraj Dommaraju, MD have Open Payments data?

Sujithraj Dommaraju, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.